PubRank

Ryuta Asano

Author PubWeight™ 14.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J 2013 2.19
2 Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair. J Am Coll Cardiol 2003 2.16
3 Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): study design and rationale. Catheter Cardiovasc Interv 2013 1.37
4 Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. Eur Heart J 2005 0.86
5 Rotational atherectomy followed by cutting-balloon plaque modification for drug-eluting stent implantation in calcified coronary lesions. J Invasive Cardiol 2012 0.83
6 Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT). Cardiovasc Interv Ther 2014 0.82
7 Preoperative left atrial emptying fraction is a powerful predictor of successful maze procedure. Circ J 2008 0.81
8 Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy. J Cardiol 2002 0.81
9 Early and long-term outcomes of coronary artery bypass grafting and percutaneous coronary intervention in patients with left main disease: single-center results of multidisciplinary decision making. Gen Thorac Cardiovasc Surg 2013 0.79
10 Late stent malapposition with marked positive vascular remodeling observed only at the site of drug-eluting stents after multivessel coronary stenting. Heart Vessels 2009 0.79
11 Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease. Heart Vessels 2012 0.78
12 Iatrogenic renal artery dissection uncommon complication during aortic endovascular repair. JACC Cardiovasc Interv 2010 0.78
13 Delayed enhancement cardiovascular magnetic resonance as a novel technique to predict cardiac events in dilated cardiomyopathy patients. Int J Cardiol 2009 0.78
14 The echocardiographic determinants of functional mitral regurgitation differ in ischemic and non-ischemic cardiomyopathy. Int J Cardiol 2006 0.77
15 Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET). Cardiovasc Interv Ther 2013 0.76
16 Etiology of aortic valve disease and recent changes in Japan:a study of 600 valve replacement cases. Int J Cardiol 2002 0.76
17 Excessive axial plaque redistribution during coronary stent implantation confirmed by intravascular ultrasound. Cardiovasc Revasc Med 2012 0.75
18 A 70-year-old woman with cardiogenic shock and change in acute electrocardiogram patterns. Left main shock syndrome/acute LMT occlusion. J Cardiol 2002 0.75
19 Impact of a preoperative mitral regurgitation scoring system on outcome of surgical repair for mitral valve prolapse. Am J Cardiol 2003 0.75
20 Normalization of left ventricular parameters following combined pimobendan and carvedilol treatment in a case of unclassified cardiomyopathy with longstanding refractory status. Intern Med 2002 0.75
21 Preventive effect of N-acetylcysteine on contrast-induced nephropathy following coronary angiography and angioplasty. Yakugaku Zasshi 2008 0.75
22 Long-term outcome of first-generation metallic coronary stent implantation in patients with coronary artery disease: observational study over a decade. Circ J 2007 0.75